The Effects of Nateglinide and Acarbose on the Post-Prandial Glucose Control in Type 2 Diabetic Patients

NCT00437918 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

85

Enrollment

OTHER

Sponsor class

Conditions

Diabetes Mellitus
Type 2 Diabetes Mellitus

Interventions

DRUG: nateglinide
DRUG: acarbose

Sponsor

Inje University

Collaborators

[object Object]